Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)

The summary for the Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4): This FOA will support the conduct of advanced clinical trials designed to test the outpatient clinical safety and efficacy of artificial pancreas (AP) device systems in type 1 diabetes with the objective of improving glycemic control, reducing acute complications and improving quality of life. These trials should generate data able to satisfy safety and efficacy requirements by regulatory agencies regarding the clinical testing of AP device systems.

Federal Grant Title:	Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-16-008
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.847
CFDA Descriptions:	Diabetes, Digestive, and Kidney Diseases Extramural Research
Current Application Deadline:	Mar 9, 2016
Original Application Deadline:	Mar 9, 2016
Posted Date:	Sep 2, 2015
Creation Date:	Sep 2, 2015
Archive Date:	Apr 9, 2016
Total Program Funding:	$20,000,000
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Private institutions of higher education
Small businesses
State governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-16-008.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...; • Diabetes Research Centers (P30 Clinical Trial Optional); • Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical ...; • Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinic...; • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes; • Molecular Therapy Core Centers; • Pilot and Feasibility Program in Human Islet Biology
More Grants from the National Institutes of Health: • Single Source Renewal for the Continuation of the Liver Cirrhosis Network: Scientific and ...; • NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34); • Limited Competition: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic ...; • Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional); • Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Train...